日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Companies

US company partners with Chinese firm to tackle rare disease

Xinhua | Updated: 2017-09-27 09:13

SHANGHAI — Staff with US company Amicus Therapeutics regularly travel to Shanghai to work out how to develop a new drug to treat Pompe disease, a rare muscle disorder.

John Crowley, chief executive of the company, led the recent trip to its Chinese partner WuXi Biologics, based in Shanghai.

Crowley said the new drug was expected to reduce the side effects of existing enzyme replacement therapy.

The disorder prevents the human body from making enough of an enzyme used by heart and muscle cells to convert a form of sugar called glycogen into energy. When glycogen builds up in these cells it can lead to swelling of the heart, disability and early death.

Crowley has led a personal struggle to save his daughter and son, who are afflicted with Pompe disease.

Crowley said his company chose WuXi Biologics as its contract manufacturer, even though some company board members questioned the decision, doubting such high-quality drugs could be made by a Chinese firm.

Currently, the drug is in stage two of clinical trials, and around 20 patients are being tested with the drug in the United States.

By the middle of next year, it is expected to enter stage three, and be applied to more patients for tests, Crowley said.

Chinese patients are expected to be included in the trials, he said. Gao Ru, founder of a Chinese Pompe patient association, said the cooperation would benefit Chinese patients. She estimated there are about 35,000 Pompe patients in China.

Gao said she managed to contact about 100 of them, 80 percent of whom were adults, and 20 percent babies.

For an adult patient, the annual medical cost is around 3 million yuan (about $460,000).

"I hope the cost for the prescription can be reduced," she said.

Crowley helped founded Novazyme, a company working on Pompe disease treatment. The company was was acquired by Genzyme in 2011. Now Paris-based Sanofi SA owns the drugs. He later founded Amicus Therapeutics to develop therapy for rare disease including Pompe.

"If you compare ordinary drugs to a bicycle, bio-medicine is like a plane. It is very difficult to make," said Chen Zhisheng, CEO of WuXi Biologics.

"The new generation drugs to treat Pompe diseases needs to be very accurate in dealing with the disorder. Both our companies will be committed to the development of the drugs until they are put on the market and bring benefits to patients," Chen said.

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 四虎国产成人永久精品免费 | 欧美日韩国产中文 | 国产精品久久久久av | a网站在线观看 | 成人精品区 | 成人精品自拍 | 久久久久久久99 | 亚洲午夜精品久久久久久浪潮 | 国产又粗又硬又长 | 天堂成人国产精品一区 | 人与动物性xxxx | 欧美日韩综合视频 | 欧美一卡二卡 | 日韩精品在线观看免费 | 亚洲第一色播 | 日韩精品高清视频 | 五月天婷婷综合 | 韩国三级久久 | 狠狠综合网 | 99精品毛片 | 国产精品久久久久久亚洲影视 | 天天精品综合 | 成人国产视频在线观看 | 欧美成人精品激情在线观看 | 亚洲免费网址 | 四虎1515| 日韩中文一区二区 | 涩涩一区| 四虎影院网站 | 色综合色综合 | 亚洲精品1 | 手机在线播放av | 波多野结衣三区 | 天天做夜夜爽 | 看av的网址| 四虎黄色影院 | 精品国产福利 | 日韩欧美操 | 日韩三级av| 成人久久久久 | 国产午夜精品一区二区三区 |